More on Cyclarity

#1

Given that things will go as planned, the quickest time we can expect the full approval would be 2030, according to what Dr. Matthew O’Connor, CEO of Scientific Affairs at Cyclarity Therapeutics, told us in a recent interview. The company is interested in pursuing accelerated and adaptive approaches “to bring our therapy to people as soon as it’s ready.”

And when do things go as planned? :smiley: But we can hope.

4 Likes
#2

Yes, certainly something to watch. It’s exciting because it doesn’t rely on broadly eliminating cells (like senolytics) but rather it is restorative by treating atherosclerosis at the cellular level.

1 Like
#3

I was hoping it would be sooner. I’m counting on this one to bring me back from the edge.

1 Like